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Abstract. A disruption to circadian rhythmicity and the sleep/wake cycle constitutes a major feature of Alzheimer’s disease
(AD). The maintenance of circadian rhythmicity is regulated by endogenous clock genes and a number of external Zeitgebers,
including light. This study investigated the light induced changes in the expression of clock genes in a triple transgenic model
of AD (3 × Tg-AD) and their wild type littermates (Non-Tg). Changes in gene expression were evaluated in four brain
areas–suprachiasmatic nucleus (SCN), hippocampus, frontal cortex and brainstem–of 6- and 18-month-old Non-Tg and
3 × Tg-AD mice after 12 h exposure to light or darkness. Light exposure exerted significant effects on clock gene expression
in the SCN, the site of the major circadian pacemaker. These patterns of expression were disrupted in 3 × Tg-AD and
in 18-month-old compared with 6-month-old Non-Tg mice. In other brain areas, age rather than genotype affected gene
expression; the effect of genotype was observed on hippocampal Sirt1 expression, while it modified the expression of genes
regulating the negative feedback loop as well as Ror, Csnk1ε and Sirt1 in the brainstem. In conclusion, during the early
development of AD, there is a disruption to the normal expression of genes regulating circadian function after exposure
to light, particularly in the SCN but also in extra-hypothalamic brain areas supporting circadian regulation, suggesting a
severe impairment of functioning of the clock gene pathway. Even though this study did not demonstrate a direct association
between these alterations in clock gene expression among brain areas with the cognitive impairments and chrono-disruption
that characterize the early onset of AD, our novel results encourage further investigation aimed at testing this hypothesis.
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INTRODUCTION
Biological processes exhibit daily rhythms that
enable organisms to coordinate their physiological
activities with changes in demand over a day. In mam-
mals, these rhythms exhibit a periodicity of about
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24 h and are endogenously generated by the master
circadian pacemaker located in the suprachiasmatic
nucleus (SCN) of the anterior hypothalamus [1].
These rhythms are synchronized by regularly recur-
ring environmental cues or “Zeitgebers”. Circadian
biological clocks are entrained to a 24 h day/night
cycle through the influence of light, the main Zeitge-
ber [2, 3]. Light is transduced into a neural signal by
the retina and conveyed to the core of the SCN [4],
which responds to light/dark cycles and co-ordinates
circadian function, including locomotor activity, hor-
mone secretion, body temperature maintenance, and
feeding. The molecular and cellular basis of circa-
dian rhythmicity consists of a complex interaction
between specialized transcription factors, commonly
described as the clock pathway, which represents
an internal timekeeping system that interacts with
these Zeitgebers [5, 6]. The generation and modu-
lation of circadian rhythms rely on interconnected,
self-sustained transcriptional/translational feedback
loops, which result in the activation or repression of
gene expression.
Alzheimer’s disease (AD) is the most frequent
form of dementia and one of the most devastat-
ing psychiatric disorders [7] and is characterized by
the accumulation of extracellular amyloid- (A)
plaques, neurofibrillary tangles (NFTs) composed of
hyperphosphorylated tau, neuronal loss, and neuroin-
flammation [8, 9]. As well as severe cognitive deficits,
patients with AD exhibit profound disruptions to their
circadian rhythms in sleep–wakefulness and other
processes. In recent years, increasing efforts have
been made to better understand the molecular and
cellular basis of the sleep disturbances and disrupted
circadian rhythms observed frequently in AD patients
[10, 11]. The clock pathway is crucially involved in
the maintenance of such rhythmicity, and studies link-
ing this molecular family to brain and body processes
in AD patients can further elucidate the etiopathogen-
esis of this common dementia [12, 13]. Therefore,
the investigation of the interactions of A and NFTs
with the clock gene pathway represents an interesting
challenge for researchers.
A distributed network of extra SCN brain regions
contains autonomous oscillators, which support cir-
cadian function [3, 14]. In common with the SCN,
these secondary oscillators also rely on feedback
loops comprising clock genes and proteins. How-
ever, the role of the clock pathway in the SCN and
extra-SCN regions is thought to be distinct and reflec-
tive of the particular function of each brain region
[14]. Therefore, the disruption to the expression of
clock genes in specific areas of the brain might con-
tribute to the clinical phenomenology of AD although
it cannot address the question as to whether this dis-
ruption is a cause or an effect of the neurodegenerative
processes.
The diversity of secondary clocks in the brain,
their specific sensitivities to temporal cues, as well
as their differential coupling to the master SCN
clock, allows the circadian timing system to inte-
grate and plastically respond to a wide range of
temporal information. This raises the possibility that
pathophysiological alterations of internal timing that
are deleterious for health may result from desyn-
chronization within this network of cerebral clocks
[15]. The main brain areas affected by AD pathol-
ogy are the cortex and the hippocampus, and recently
morphological changes have been also reported in
the brainstem [16]. Information on the molecular
function of the clock pathway in different areas of
AD afflicted brains is still limited, therefore this
study aimed to evaluate the expression of the core
genes comprising the clock pathway of the SCN
and three other brain areas, such as hippocampus,
frontal cortex and brainstem in a well-characterized
triple transgenic murine model of AD (3 × Tg-AD)
[17–19].
The 3 × Tg-AD mice develop amyloid plaques and
neurofibrillary pathology in a hierarchical manner
in AD-relevant brain regions, develop age-related
cognitive decline, and closely mimic the disease pro-
gression in humans [17–19]. For the purpose of our
study, we have evaluated the clock gene expression at
two different stages of the disease in the 3 × Tg-AD
mice. In particular, mice have been studied at 6 and 18
months of age, which corresponds to mild and severe
pathology of AD-like symptoms, respectively. The
control animals were age- and sex-matched, cogni-
tively normal non-transgenic (Non-Tg) mice. Based
on our earlier work [18–21], the youngest group of
animals (6 months of age) was expected to show
intraneuronal A, somatodendritic tau accumulation
and was named the mild pathology group. The sec-
ond age group (18 months of age) was expected
to develop extensive A plaque burden, mature
NFTs, along with signs of activated microglia, strong
signs of plaque-associated inflammation, and was
named the severe pathology group [18]. Although
this study was not designed to demonstrate a direct
association between clock gene alteration and cir-
cadian rhythms or sleep-wake cycle, our findings
open new perspectives on the chronopathology
of AD.
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MATERIALS AND METHODS
Animal model
All animals received care in compliance with the
Principles of Laboratory Animal Care formulated
by the National Society for Medical Research and
the guide for the Care and Use of Laboratory Ani-
mals prepared by the Institute of Laboratory Animal
Resources, published by the National Institutes of
Health (NIH Publication No. 86–23, revised 1985),
as well as with Italian laws on animal experimenta-
tion. All efforts were made to minimize the number
of animals used in the study.
6-month-old (adult) and 18-month-old (aged)
3 × Tg-AD male mice and their wild type male lit-
termates (Non-Tg) were housed at the animal facility
of the Puglia and Basilicata Experimental Zoopro-
phylactic Institute (Foggia, Italy), according to the
procedures described previously [18, 19]. Genotypes
were confirmed by polymerase chain reaction (PCR)
after tail biopsies as previously described [18, 19].
Fresh food and water were freely available, and
the housing conditions were controlled, with temper-
ature 22◦C, humidity 50–60%, a 12 h light (L)-12 h
dark (D) cycle, with light on at Zeitgeber Time (ZT)
0 corresponding to Circadian Time (CT) 07:00 h and
light off at ZT12 corresponding to CT 19:00 h. A full-
spectrum white fluorescent lamp (526 lux) served as
a daytime light source. On the day of the experiment,
mice were decapitated at CT 07:00 h (after exposure
to D) or at CT 19:00 h (after exposure to L); the brains
were rapidly removed and placed on a cold surface to
dissect the suprachiasmatic nucleus, frontal cortex,
hippocampus, and the brainstem following a pro-
cedure obtained by modifying a previous published
protocol [22]. All the tissues were then snap frozen in
liquid nitrogen and stored at –80◦C. Because of the
small amount of tissue available, each sample was
obtained by pooling tissues from 2 animals (for a
total of 12 mice per group).
RNA extraction from fresh frozen tissue and
first-strand cDNA synthesis
Tissues from brain areas stored at –80◦C were
homogenized and total RNA was extracted by
RNeasy Lipid Tissue Mini Kit (QIAGEN GmbH,
Germany) as recommended by the manufacturer. All
RNA samples were quantified by measuring the opti-
cal density (NanoDrop ND-1000 Spectrophotometer,
NanoDrop Technologies). Quality and purity of
the samples were analyzed by gel electrophoresis.
Complementary DNA was generated from these sam-
ples using M-MLV Reverse Transcriptase according
to the manufacturer’s instructions (Invitrogen,
Carlsbad, CA, USA).
Quantitative real-time reverse transcription-
polymerase chain reaction (RT-PCR)
Real-time quantification of mRNA was performed
with a SYBR Green I assay, and evaluated using
an iCycler detection system (Bio-Rad Laborato-
ries). The threshold cycle (CT) was determined,
and the relative genes expression subsequently
was calculated as follows: fold change = 2−(CT),
where CT = CT target – CT housekeeping and
(CT) = CT treated – CT controls. All PCR
primer pairs, purchased from Sigma-Aldrich (KiC-
qStartTM SYBR® Green qPCR ReadyMix TM, iQ,
Sigma-Aldrich), are listed in Supplementary Table 1.
Immunohistochemistry
Mice (n = 3 per group) were intra-cardioven-
tricularly perfused with saline followed by fixation
solution (4% paraformaldehyde in 0.1 M phos-
phate buffer, PB, pH 7.4). Free-floating coronal
sections of 50m thickness were obtained using a
vibratome slicing system (microM, Walldorf, Ger-
many). Immunohistochemistry was performed using
peroxidase-based detection system. Endogenous per-
oxidase activity was quenched for 30 min in 0.3%
H2O2. The brain sections were blocked with 10%
normal goat serum/PBS with 0.3% Triton X-100 and
then incubated overnight at 4◦C with the follow-
ing antibodies: mouse monoclonal 6E10 antibody
(1:3000 dilution, Signet Laboratories) for total amy-
loid; and human-specific anti-tau antibody HT7
(1:1000 dilution, Pierce Biotechnology) [20]. After
removing the primary antiserum in excess, sections
were incubated with secondary antibody (Biotin-SP-
conjugated fragment donkey anti rabbit IgG) for 1 h at
room temperature. After washing excess of antibody,
sections were treated with avidin–biotin–peroxidase
complex (ABC, 1:200 dilution, Vector Laborato-
ries) and then developed with diaminobenzidine
substrate using the avidin-biotin horseradish peroxi-
dase system (Vector Laboratories). Immunolabeled
sections were viewed using a Nikon 80i Eclipse
microscope equipped with a DS-U1 digital cam-
era, and NIS-elements BR software (Nikon, Tokyo,
Japan). Semiquantitative analyses of the signal of A
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and tau immunostaining were performed using free-
ware software from the National Institutes of Health
(Scion Image software) and were expressed as optical
densities.
Statistics
All data were expressed as mean ± standard error
of the mean (SEM) of fold change values. Within-
group variability was analyzed through Levene’s test
for homogeneity of variances. Data were analyzed
using three-way analysis of variance (ANOVA), to
test the main effects of D/L cycle (Dark versus Light),
genotype (G) (3 × Tg-AD versus Non-Tg), age (A)
(6 months versus 18 months of age) as between-
subject factors; the interactions D/L × G, D/L × A,
G × A and D/L × A × G were studied and a Tukey
test was used as a post-hoc test for multiple com-
parisons. The correlation analysis between A or
tau protein levels and clock gene expression was
performed by using the Pearson correlation test.
The threshold for statistical significance was set
at p < 0.05. The SPSS Statistics version 19 (IBM,
Armonk, NY, USA) and GraphPad Prism 6 for Win-
dows (GraphPad Software Inc., San Diego, CA, USA)
were used to perform all the statistical analyses and
to represent graph data, respectively.
RESULTS
Effect of D/L exposure on gene expression in the
clock pathway in the suprachiasmatic nucleus
(SCN) of 6- and 18-month-old 3×Tg-AD and
Non-Tg mice
Since the major circadian pacemaker in mammals
is located in the SCN, we first determined whether the
variations in clock gene expressions occurring after a
12 h D/L cycle was observed in the 6- and 18-month-
old 3 × Tg-AD and Non-Tg mice littermates, referred
as the mild and severe pathology group, respectively
(Fig. 1). To this aim, animals were sacrificed at
CT 07:00 h (after exposure to D) or at CT 19:00 h
(after exposure to L) and the variability of core clock
gene expressions was analyzed. The results obtained
by the statistical analysis aimed to test the main
effects of D/L, G, A and the interactions D/L × G,
D/L × A, G × A, and D/L × A × G are shown in
Table 1.
The main effect of D/L cycle was significant for the
expression of the core clock genes Bmal1 and Clock,
as well as the component of the negative feedback
loop Cry2. The main effect of genotype was signifi-
cant for the expression of Cry1, Cry2, and Per1, all
coding for proteins of the negative feedback loop;
moreover, the main effect of age was significant for
the expression of all the genes studied, except for
Clock. The interaction between the D/L cycle and
genotype was significant only for Clock expression,
while the interaction between the D/L cycle and age
was significant for Cry2 expression; interestingly, the
interaction between genotype and age was significant
for Bmal1, Cry1, Cry2, and Per1 expression. Finally,
the interaction of the three variables was significant
for the expression of Bmal1, Clock, and Sirt1.
Post-hoc analysis showed an interesting picture of
how D/L cycle, genotype and age affected the expres-
sion of clock genes in the SCN (Fig. 1). Bmal1 was
significantly upregulated after a 12 h exposure to L in
both 6- and 18-month-old Non-Tg mice (+86% and
+73%, respectively; Fig. 1a), while it was not modi-
fied or significantly downregulated (–50%) after 12-h
L exposure in 6- and 18-month-old 3 × Tg-AD mice,
respectively. Interestingly, Bmal1 expression in 18-
month-old 3 × Tg-AD mice was significantly higher
(+111%) compared to 18-month-old Non-Tg mice
after a 12 h exposure to darkness.
The expression of Clock was significantly higher
(+115%) only in 6-month-old Non-Tg mice after 12 h
exposure to L, but no significant differences were
observed in the 6-month-old 3 × Tg-AD and both
18-month-old Non-Tg and 3 × Tg-AD mice (Fig. 1b).
Expression in the negative feedback loop (com-
posed by Per-Cry genes) was also disrupted in
3 × Tg-AD mice. We observed a lower expression
of Cry1 and Per1 (–61% and –72%, respectively)
after a 12 h exposure to L in 6-month-old Non-Tg
mice. In the SCN of 6-month-old 3 × Tg-AD, Cry1
was significantly upregulated (+77%), while Per1
was not modified. Moreover, the RNA expression of
both genes was not significantly modified after D/L
exposure in 18-month-old mice of both genotypes
(Fig. 1c, e). Interestingly, Cry1 expression in 6-
month-old 3 × Tg-AD mice was significantly higher
(+345%) compared to 6-month-old Non-Tg mice
after 12 h exposure to L (Fig. 1c).
Nr1d1 andRor are both targets of the heterodimer
CLOCK-BMAL1 and regulate, in turn, the expres-
sion of Bmal1 [23]. In our study, Nr1d1 expression
was upregulated (+56%) after 12 h L exposure in
6-month-old Non-Tg mice, while no significant dif-
ference was observed after D/L exposure in both
6-month-old 3 × Tg-AD and 18-month-old mice of
both genotypes (Fig. 1h).
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Fig. 1. Clock gene expression level in the suprachiasmatic nucleus (SCN) of 6-month-old and 18-month-old Non-Tg and 3 × Tg-AD mice
after 12 h exposure to darkness (D) or light (L). Data are expressed as mean ± SEM of fold change values and were analyzed by 3-way
ANOVA. Tukey’s post-hoc test was used where appropriate to perform multiple comparisons. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
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Table 1
Results from the three-way ANOVA of clock gene expression in the suprachiasmatic nucleus of 6-month and 18-month-old Non-Tg and
3 × Tg-AD mice after a 12 h D/L cycle (n = 12 per group). D, darkness; L, light; G, genotype; A, age; F, Fisher’s test. ∗p < 0.05; ∗∗p < 0.01;
∗∗∗p < 0.001
D/L G A D/L × G D/L × A G × A D/L × G × A
Bmal1 F 27.78∗∗∗ 0.09 8.54∗∗ 0.61 2.75 10.11∗∗ 6.72∗
Clock F 7.96∗ 3.64 1.87 7.65∗ 0.26 0.29 6.44∗
Cry1 F 0.18 5.60∗ 30.47∗∗∗ 3.45 0.16 6.84∗ 2.65
Cry2 F 16.78∗∗ 19.76∗∗∗ 100.2∗∗∗ 0.21 16.35∗∗ 20.49∗∗∗ 0.29
Per1 F 0.19 7.49∗ 31.64∗∗∗ 1.85 0.11 9.05∗∗ 2.01
Per2 F 0.00 0.14 33.86∗∗∗ 0.72 0.84 0.42 1.76
Per3 F 0.01 0.00 34.64∗∗∗ 1.66 2.21 1.04 4.15
Nr1d1 F 0.08 0.76 42.30∗∗∗ 0.02 0.32 1.80 0.12
Ror F 1.00 0.42 6.78∗ 2.93 0.99 0.49 3.40
Csnk1 F 2.49 0.10 12.24∗∗ 0.01 2.97 0.12 0.20
Sirt1 F 0.14 0.01 152.1∗∗∗ 2.69 0.15 0.10 6.52∗
As far as Ror, we observed an upregulation
(+68%) in the 6-month-old Non-Tg mice and, con-
versely, a downregulation (–38%) in the 6-month-old
3 × Tg-AD mice, while no significant difference
was observed after D/L exposure in 18-month-old
mice of both genotypes (Fig. 1i). Interestingly, Ror
expression in 6-month-old 3 × Tg-AD mice was sig-
nificantly lower (–48%) compared with 6-month-old
Non-Tg mice after 12 h exposure to L (Fig. 1i).
Casein kinase 1 epsilon (CSNK1ε) phosphorylates
PER proteins promoting their degradation through
a proteasomal pathway [24]. Interestingly, Csnk1ε
was downregulated (–75%) after 12 h L exposure
in 6-month-old Non-Tg mice, while no significant
difference was observed after D/L exposure in both
6-month-old 3 × Tg-AD and 18-month-old mice of
both genotypes (Fig. 1j).
The NAD-dependent deacetylase SIRT1 activates
the transcription of both Bmal1 and Clock in the
SCN [25]. In this context, we observed a signifi-
cant upregulation (+221%) of Sirt1 in 6-month-old
Non-Tg mice after 12 h L exposure, while no
significant difference was observed after D/L expo-
sure in both 6-month-old 3 × Tg-AD and 18-month-
old mice of both genotypes (Fig. 1k). Interestingly,
Sirt1 expression in 6-month-old 3 × Tg-AD mice was
significantly higher (+240%) compared to 6-month-
old Non-Tg mice after a 12 h exposure to darkness.
Effect of D/L exposure on gene expression in the
clock pathway of the hippocampus of 6- and
18-month-old 3×Tg-AD and Non-Tg mice
Clock genes are expressed in various parts of
the central nervous system constituting a distributed
circadian network with different degrees of auton-
omy and SCN-dependence [26]. Therefore, we first
investigated the expression of clock genes in the hip-
pocampus, which is one of the brain regions mainly
affected by the neuropathological alterations of
AD [27].
The results obtained by the statistical analysis
aimed to test the main effects of D/L cycle, G, A, and
the interactions between D/L × G, D/L × A, G × A,
Table 2
Results from the three-way ANOVA of clock gene expression in the hippocampus of 6-month and 18-month-old Non-Tg and 3 × Tg-AD
mice after a 12 h D/L cycle (n = 12 per group). D, darkness; L, light; G, genotype; A, age; F, Fisher’s test. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001
D/L G A D/L × G D/L × A G × A D/L × G × A
Bmal1 F 11.40∗∗ 0.69 7.49∗ 2.27 10.39∗∗ 0.40 1.47
Clock F 5.91∗ 0.73 2.49 0.01 9.92∗∗ 0.22 0.06
Cry1 F 0.64 0.01 16.18∗∗ 0.02 19.51∗∗∗ 0.12 0.35
Cry2 F 7.44∗ 0.38 8.06∗ 0.45 6.42∗ 0.37 0.20
Per1 F 3.32 1.57 24.20∗∗∗ 0.78 4.13 2.45 1.06
Per2 F 1.89 0.58 12.34∗∗ 0.24 2.94 0.87 0.53
Per3 F 0.39 0.36 14.02∗∗ 4.02 1.04 2.00 4.44∗
Nr1d1 F 3.87 0.02 13.21∗∗ 0.55 5.93∗ 0.24 0.61
Ror F 2.59 0.37 6.60∗ 1.54 2.98 0.33 1.71
Csnk1 F 13.96∗∗ 0.98 33.13∗∗∗ 0.02 12.14∗∗ 0.90 0.29
Sirt1 F 11.36∗∗ 12.21∗∗ 22.40∗∗∗ 4.40∗ 11.35∗∗ 11.73∗∗ 4.70∗
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and D/L × A × G are shown in Table 2. Similarly
to the SCN, we observed a significant main effect
of D/L cycle on the expression of core clock genes
Bmal1 and Clock, as well as the component of the
negative feedback loop Cry2; moreover, the main
effect of D/L cycle was significant for the expression
of Csnk1ε and Sirt1 in the hippocampus. The main
effect of genotype was significant only for the
expression of Sirt1, while the main effect of age was
observed for the expression of all the genes studied,
except for Clock. The interaction between D/L and
genotype was significant for Sirt1 expression, while
the interaction between D/L and age was significant
for Bmal1, Clock, Cry1-2, Nr1d1, Csnk1ε, and
Sirt1. The interaction between genotype and age
was significant for Sirt1 expression. Finally, the
interaction among the three factors was significant
for the expression of Per3 and Sirt1 (Table 2). As
reported in the Fig. 2, the post-hoc analysis showed
a significant downregulation (–49%) of Cry1 after
12 h L exposure in 6-month-old Non-Tg mice,
while no significant difference was observed after
D/L exposure in both 6-month-old 3 × Tg-AD and
18-month-old mice of both genotypes (Fig. 2c).
Moreover, the exposure to D/L cycle caused the
upregulation (+59%) of Sirt1 only in 18-month-old
Non-Tg mice, while no significant difference was
observed after D/L exposure in both 18-month-old
3 × Tg-AD and 6-month-old mice of both genotypes
(Fig. 2k). Interestingly, Sirt1 expression in 18-month-
old 3 × Tg-AD mice was significantly lower (–80%)
compared to 18-month-old Non-Tg mice after a 12 h
exposure to L (Fig. 2k).
Effect of D/L exposure on expression of genes of
the clock pathway in the frontal cortex of 6- and
18-month-old 3×Tg-AD and Non-Tg mice
Gene expression in the clock pathway was then
analyzed in the frontal cortex.
The results obtained by the statistical analysis
aimed to test the main effects of D/L cycle, G, A
and the interactions D/L × G, D/L × A, G × A, and
D/L × A × G are shown in Table 3. The main effect
of D/L cycle was significant for the expression of
Bmal1; overall the main effect of genotype was not
significant, while the main effect of age was sig-
nificant on the expression of all the genes studied,
except for Sirt1. The interaction between the D/L
cycle and age was significant for Bmal1, Clock, Cry1-
2, and Per3; no further significant interactions were
observed (Table 3).
As reported in the Fig. 3c, the post-hoc analysis
showed a significant downregulation (–51%) of Cry1
after 12 h L exposure in 6-month-old Non-Tg mice,
while no significant difference was observed after
D/L exposure in both 6-month-old 3 × Tg-AD and
18-month-old mice of both genotypes.
Moreover, after 12 h L exposure we observed
a significant downregulation of Per1, 2, and 3 in
6-month-old 3 × Tg-AD mice (–51%, –52%, and
–44%, respectively), while no significant difference
was observed after D/L exposure in both 6-month-old
Non-Tg and 18-month-old mice of both genotypes
(Fig. 3e-g). Interestingly, Per1 and Per3 expression
in 6-month-old 3 × Tg-AD mice was significantly
higher (+85% and +82%, respectively) compared to
6-month-old Non-Tg mice after 12 h exposure to D
(Fig. 3e, g).
Effect of D/L exposure on gene expression of the
clock pathway in the brainstem of 6- and
18-month-old 3×Tg-AD and Non-Tg mice
We then evaluated the expression of clock genes
in the brainstem, which is connected with the
SCN by the neural circuits regulating sleep-wake
rhythms [28].
The results obtained by the statistical analysis
aimed to test the main effects of D/L cycle, G, A
and the interactions D/L × G, D/L × A, G × A, and
D/L × A × G are shown in Table 4. We observed a
significant main effect of the D/L cycle on the expres-
sion of Bmal1, Cry2, Per1, Ror, and Csnk1ε. The
main effect of genotype was significant on the expres-
sion of Cry1-2 and Per1, as well as Ror, Csnk1ε,
and Sirt1. The main effect of age was a significant
factor in the expression of all the genes studied,
except for Clock and Cry1. The main effect of an
interaction between the D/L cycle and genotype was
significant for Bmal1 and Cry1-2 expression, while
the interaction between the D/L cycle and age was
significant for Bmal1, Cry1-2 and Per1 expression;
moreover, the main effect of interaction between
genotype and age was significant for Cry1-2, Per1,
Ror, Csnk1ε, and Sirt1 expression. The main effects
of interaction among the three factors was signifi-
cant for the expression of Cry2, Per1, and Csnk1ε
(Table 4).
As reported in the Fig. 4a, the post-hoc anal-
ysis showed a significant upregulation of Bmal1
expression after 12 h L exposure only in the 6-month-
old Non-Tg mice (–321%), while no significant
difference was observed in both the 6-month-old
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Fig. 2. Clock gene expression level in the hippocampus (H) of 6-month-old and 18-month-old Non-Tg and 3 × Tg-AD mice after 12 h
exposure to darkness (D) or light (L). Data are expressed as mean ± SEM of fold change values and analyzed by 3-way ANOVA. Tukey’s
post hoc test was used where appropriate to perform multiple comparisons. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
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Table 3
Results from the three-way ANOVA of clock gene expression in the frontal cortex of 6-month and 18-month-old Non-Tg and 3 × Tg-AD
mice after a 12 h D/L cycle (n = 12 per group). D, darkness; L, light; G, genotype; A, age; F, Fisher’s test. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001
D/L G A D/L × G D/L × A G × A D/L × G × A
Bmal1 F 11.40∗∗ 0.02 12.84∗∗ 0.29 5.58∗ 0.45 1.17
Clock F 1.95 0.01 6.92∗ 0.22 4.23∗ 0.51 0.01
Cry1 F 0.02 0.03 26.46∗∗∗ 0.18 5.24∗ 0.02 0.37
Cry2 F 1.88 0.08 16.64∗∗ 0.15 4.71∗ 0.02 0.14
Per1 F 1.70 0.45 7.06∗ 0.02 3.68 0.01 0.13
Per2 F 0.28 1.47 19.50∗∗∗ 0.62 2.81 0.59 0.31
Per3 F 0.88 1.43 17.23∗∗ 0.04 4.97∗ 0.01 0.17
Nr1d1 F 0.27 0.38 16.77∗∗ 0.69 0.52 0.03 0.98
Ror F 2.59 1.81 4.72∗ 0.25 2.27 0.23 0.27
Csnk1 F 2.60 0.88 22.45∗∗∗ 0.07 3.79 0.01 0.13
Sirt1 F 2.04 0.85 1.61 0.00 2.76 0.37 0.93
3 × Tg-AD and 18-month-old mice of both geno-
types.
Cry1 expression in 6-month-old 3 × Tg-AD mice
was significantly higher (+212%) compared to 6-
month-old Non-Tg mice after a 12 h exposure to D
(Fig. 4c).
Moreover, Cry2 was upregulated (+471%) in 18-
month-old Non-Tg mice after a 12 h L exposure
(Fig. 4d). Interestingly,Cry2 expression in 18-month-
old 3 × Tg-AD mice was significantly lower (–74%)
compared to 18-month-old Non-Tg mice after a 12 h
exposure to L (Fig. 4d).
Per1 was downregulated (–54%) in 6-month-old
3 × Tg-AD mice after a 12 h L exposure (Fig. 4e).
Interestingly,Per1 expression in 6-month-old 3 × Tg-
AD mice was significantly higher compared to
6-month-old Non-Tg mice after a 12 h exposure
to D and L (+444% and 467%, respectively,
Fig. 4e).
As far as Nr1d1, the expression in 6-month-old
3 × Tg-AD mice was significantly higher (+131%)
compared to 6-month-old Non-Tg mice after a 12 h
exposure to D (Fig. 4h).
Moreover, the expression of Csnk1ε was signif-
icantly higher (+237%) in 6-month-old 3 × Tg-AD
mice compared to 6-month-old Non-Tg mice after a
12 h exposure to L (Fig. 4j).
Finally, after a 12 h L exposure we observed
an upregulation (+989%) of Sirt1 expression in
6-month-old Non-Tg mice, while no significant
differences were observed after D/L exposure in
both 6-month-old 3 × Tg-AD and 18-month-old
mice of both genotypes (Fig. 4k). Interestingly,
Sirt1 expression in 6-month-old 3 × Tg-AD mice
was significantly higher (+347%) compared to 6-
month-old Non-Tg mice after a 12 h exposure to L
(Fig. 4k).
Alterations of clock gene expression and
neuropathology
To verify whether variations in the clock path-
way were related to brain pathology in the transgenic
model, immunohistochemical analysis of both A
and tau was performed in all the areas where the
clock gene expression was investigated. As previ-
ously reported, no immunostaining was detected in
the SCN and in the brainstem (data not shown) [17].
As the 3 × Tg-AD mice age, they gradually
accumulate A and tau pathology in their brains.
Specifically, 6-month old 3 × Tg-AD mice showed a
significant increase in A immunostaining compared
to age-matched Non-Tg mice, while no difference
was found in tau immunoreactivity at this age in
both the frontal cortex and the hippocampus. Finally,
we found dense A deposits and extensive human
tau immunoreactivity in the frontal cortex and hip-
pocampus of 18-month-old 3 × Tg-AD mice. None
of these immunoreactive structures were detected in
the Non-Tg brains (Fig. 5a).
Moreover, the application of a Pearson correlation
test did not find any relationship between modifi-
cation of clock gene expression and A deposition
or tau immunoreactivity in the frontal cortex. Nev-
ertheless, direct correlations between A and Per3
variation (ρ = 0.6223, p = 0.0307), tau and Per3 vari-
ation (ρ = 0.6445, p = 0.0237), as well as tau andRor
(ρ = 0.6901, p = 0.0130) were found in the hippocam-
pus (Fig. 5b-d).
DISCUSSION
The present study demonstrates that the RNA
expressions of clock genes are disrupted in both the
SCN and three extra-hypothalamic brain areas that
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Fig. 3. Clock gene expression level in the frontal cortex (FC) of 6-month-old and 18-month-old Non-Tg and 3 × Tg-AD mice after 12 h
exposure to darkness (D) or light (L). Data are expressed as mean ± SEM of fold change values and analyzed by 3-way ANOVA. Tukey’s
post hoc test was used where appropriate to perform multiple comparisons. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
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Table 4
Results from the three-way ANOVA of clock gene expression in the brainstem of 6-month and 18-month-old Non-Tg and 3 × Tg-AD mice
after a 12-hour D/L cycle (n = 12 per group). D, dark; L, light; G, genotype; A, age; F, Fisher’s test. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001
D/L G A D/L × G D/L × A G × A D/L × G × A
Bmal1 F 19.10∗∗ 0.29 19.49∗∗ 18.08∗∗ 11.66∗∗ 2.28 0.57
Clock F 1.94 3.56 0.03 2.50 1.21 1.50 1.03
Cry1 F 0.00 5.24∗ 1.29 8.61∗ 6.70∗ 23.83∗∗∗ 2.08
Cry2 F 32.74∗∗∗ 20.53∗∗∗ 69.57∗∗∗ 19.51∗∗∗ 36.61∗∗∗ 34.32∗∗∗ 13.37∗∗
Per1 F 10.43∗∗ 14.26∗∗ 25.90∗∗∗ 0.89 6.87∗ 57.84∗∗∗ 9.06∗∗
Per2 F 0.05 0.66 98.86∗∗∗ 0.06 0.08 0.60 0.08
Per3 F 0.02 0.82 107.6∗∗∗ 0.24 0.00 0.66 0.05
Nr1d1 F 0.45 0.05 83.16∗∗∗ 1.00 0.80 1.95 2.65
Ror F 7.58∗ 6.00∗ 42.50∗∗∗ 0.91 2.85 8.09∗ 1.81
Csnk1 F 4.44∗ 14.57∗∗ 18.57∗∗∗ 0.08 0.51 21.90∗∗∗ 5.02∗
Sirt1 F 2.60 24.03∗∗∗ 24.44∗∗∗ 0.05 1.24 27.02∗∗∗ 0.01
contribute to circadian regulation—the hippocampus,
frontal cortex, and brainstem—in the 6-month-old
3 × Tg-AD compared to age-matched control Non-
Tg mice. Differences between these genotypes were
observed at 6 months (the stage of mild pathology),
but then disappeared by 18 months at an increas-
ingly severe stage of pathology. These data therefore
demonstrate that, with the progression of AD, the
increasing impact of A and NFTs accumulation on
gene expression in the clock pathway were obscured
by an interaction with the normal aging process.
In the clock pathway, the clock gene product
BMAL1 and its partner CLOCK are positive regula-
tors of transcription, while others, such as CRY, PER,
and ROR, are components of a negative feedback
loop that attenuates activation of a range of endoge-
nous clock genes [23]. During the day, CLOCK and
BMAL1 heterodimerize and activate the rhythmic
transcription of Per1-3 and Cry1-2, which in turn
form complexes in the cytoplasm and then translocate
to the nucleus interacting with CLOCK-BMAL1,
which inhibit their own transcription. In a second
positive loop, the CLOCK-BMAL1 complexes acti-
vate the transcription of Nr1d1 and Ror, whose
protein products repress and activate, respectively,
Bmal1 transcription influencing its rhythmic expres-
sion. While BMAL1 level falls, the expression of Per
and Cry genes increases, proteins enter the nucleus
inhibiting their own transcription and also Rev-erb 
transcription, leading to a de-repression or activation
of Bmal1 expression, which completes and fine tunes
this transcriptional feedback loop.
The CLOCK-BMAL1 duet also drives the expres-
sion of output genes, the so-called clock controlled
genes [29–32]. The mechanism of negative feedback
loops is needed to establish and maintain circa-
dian rhythms, but the clock has further levels of
complexity including post-transcriptional regulation,
phosphorylation, ubiquitination, post-translational
modifications, and chromatin remodeling [33,
34]. Therefore, we designed our gene expression
study as previous observations of the interactions
between environmental cues and gene expression
of clock pathway transcripts have yielded important
insights into the regulatory mechanisms of circadian
function [35].
The function of circadian clocks, in common with
several physiological activities, is greatly affected
by neurodegenerative diseases [36], as well as the
aging process [37]. The most novel finding of our
study is the demonstration that gene expression
in the clock pathway is disrupted in 6-month-
old 3 × Tg-AD mice, which is accompanied with
the onset of mild pathology and cognitive impair-
ments but these disruptions were masked by the
normal ageing process and expression was not sig-
nificantly disrupted in 18-month-old 3 × Tg-AD,
compared with normal aging control. This hypothesis
is supported by clinical observations demonstrat-
ing that changes in the circadian patterns of gene
expression are significant during the normal aging
processes, but less differences are observed when
comparing elderly AD patients with age-matched
controls [38, 39]. To our opinion, it is not conceiv-
able that normal aging processes are stronger than AD
pathology in the induction of circadian disruption, but
rather that the lack of differences between 18-month-
old Non-Tg and 3 × Tg-AD mice may reflect a ceiling
effect.
In a recent postmortem study, significant differ-
ences in the RNA expression level of Per1-2 and
Bmal1 were found in the bed nucleus of the stria ter-
minalis, cingulate cortex, and the pineal gland [40].
However, there are significant methodological diffi-
culties in accurately interpreting clock pathway gene
expression in human samples, as a daytime death
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Fig. 4. Clock gene expression level in the brainstem (BS) of 6-month-old and 18-month-old Non-Tg and 3 × Tg-AD mice after 12 h exposure
to darkness (D) or light (L). Data are expressed as mean ± SEM of fold change values and analyzed by 3-way ANOVA. Tukey’s post hoc
test was used where appropriate to perform multiple comparisons. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
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Fig. 5. a) Representative microphotographs (10 × magnification, scale bar 100m) and results obtained from the semi-quantitative analyses
of A (6E10 antibody) and tau (HT7 antibody) immunostaining from Non-Tg (n = 3, white bars) and 3 × Tg-AD (n = 3, black bars) mice. The
red squares within the brain diagrams illustrate the sites where the representative microphotographs were taken. The data are mean ± SEM
∗∗p < 0.01 and ∗∗∗p < 0.001 versus age-matched Non-Tg mice (Unpaired Student’s t-test, n = 3). b-d) Scatterplot of A or tau protein levels
versus Per3 and Ror mRNA expression showing a direct correlation (Pearson test) in the hippocampus of 3 × Tg-AD mice.
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would result in differing patterns of gene expres-
sion than a nightly one [36]. To date, studies in
gene-manipulated mice commonly used as models
of AD have not provided evidence of a disruption
to clock pathway gene expression in AD, or demon-
strated the potential involvement of these genes in
the neurodegenerative process. This potential disrup-
tion in gene expression is further complicated by
the variety of transgenic mice used as AD models,
which can harbor single, double, or triple gene muta-
tions, and show different phenotypes. The 3 × Tg-AD
mice exhibit both A and tau pathology characteris-
tic of the human form of AD, and have been so far
extensively characterized in the context of biochemi-
cal, circadian, behavioral and cognitive changes [19,
41, 42]. Nevertheless, a methodological limitation
of this investigation consists in the absence of elec-
trophysiological measurement of circadian rhythms
and sleep-wake cycle, taking into account that behav-
ioral studies are characterized by environment-gene
interaction and researcher-associated bias [43, 44].
Interestingly, this present study shows that the
effects of light exposure on the expression of clock
pathway genes in the SCN were altered in the AD
model. Similar results though related to fewer genes
were observed in the brainstem, but not in the hip-
pocampus and the frontal cortex, the most affected
brain areas in AD. Changes pertaining to circadian
rhythmicity that occur prior to and post-AD pathol-
ogy have been previously characterized in 3 × Tg-AD
mice, demonstrating that abnormalities in circadian
rhythmicity precede the expected onset of AD pathol-
ogy [41]. It is interesting to note that these differences
presented in relatively young (6 months of age)
3 × Tg-AD mice who express mild pathology and
cognitive impairments, but by 18 months of age as
the pathology and cognitive impairments increase
in severity, these differences become statistically
insignificant due to an interaction with ageing. Other
studies have suggested that alterations in the expres-
sion of clock pathway genes association with AD are
only slightly observed in brain areas where pathol-
ogy develops. One rodent AD-model showed altered
expression of Per2 in the SCN, but not in the hip-
pocampus [45] and there is evidence that A could
induce degradation of BMAL1 and modulate Per2
expression [46]. Other recent reports have demon-
strated that AD-related morphological findings occur
in the hypothalamus and brainstem as well [47, 48].
It has been previously considered that the intact
circadian system may have neuroprotective func-
tions, but disruption of the circadian clock seems to
promote neurodegeneration [49]. This study showed
that correlations between amyloid plaques/NFTs
accumulation and altered expression of clock genes
were confined to the hippocampus, which is a brain
region particularly affected by AD pathology in
the 3 × Tg-AD mice. In this regard, further stud-
ies are needed to clarify the underlying molecular
mechanisms.
Previous experiments in rodents have shown that
the age-related deterioration in circadian pacemaker
function occurs at the level of individual cells in the
SCN, and it is correlated with an altered expression of
several of the genes that support the molecular func-
tion of the circadian clock [50, 51]. Moreover, it has
been described that the light-induced expression of
clock genes is modified in the SCN of aging ham-
sters [52], and that phase-shifts of the D/L cycle are
affected in the pineal gland and the arcuate nucleus
of aged rats [53]. When we examined and com-
pared expression of clock pathway genes after light
exposure as a function of aging in 6-month-old and
18-month-old animals, the main changes found as a
consequence of aging suggested that expression was
increased in aged mice. This study did not address
whether clock gene dysregulation during aging was
dependent on an impairment of the retina; however, a
recent study performed with cholera toxin tracing has
concluded that aging rather than retinal degeneration
is a more important factor in reducing the efficiency
of L or D information to the SCN [54]. Another
cause of the alteration of the circadian pacemaker
may be linked to age-related loss of sensitivity to
melatonin in the SCN [55]. A further comment should
be addressed concerning the progression of brain
pathology on altered clock gene expression as a con-
sequence of the D/L cycle in the extra-hypothalamic
brain areas. While SCN clocks are able to indepen-
dently generate and maintain their circadian oscilla-
tions, secondary clocks do require external signals to
sustain and/or synchronize their rhythms [56]. It has
then been suggested that the age-associated changes
in the SCN might account for the impairments in
circadian clock synchronization in other peripheral
clocks [35]. However, since the brain contains multi-
ple circadian oscillators in extra-hypothalamic areas,
it is also conceivable that these peripheral regions
could adapt to changes related to the pathological
process [57]. It is interesting to note that in our study
we observed the effect of light exposure on Bmal1
expression in all brain areas observed. However, this
was not associated with an effect of light exposure
on the negative feedback loop. The disruption of the
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circadian system by targeted deletions of Clock or
Bmal1 significantly affects the rate of ageing, and is
associated with increases in brain inflammation and
neurodegeneration [37, 58]. CLOCK proteins may
have other functions other than regulation of the cir-
cadian rhythm [49]. This is supported by evidence
showing accelerated neurodegeneration in mouse
models of brain-selective or conditionalBmal1 knock
out mice [59, 60]. It is then conceivable that upreg-
ulation of Bmal1 and the altered activation of the
negative feedback loop, which occurs in all the brain
areas, would represent a counteracting mechanism to
the neurodegenerative effect. However, these aspects
need to be further investigated by using different cir-
cadian mutant models.
In conclusion, our results demonstrate that a mild
AD-pathology in 6-month-old, 3 × Tg-AD mice is
associated with a disruption in the temporal patterns
and quantitative levels gene expression in the clock
pathway, particularly in the SCN but also in extra-
hypothalamic brain areas associated with circadian
function, suggesting a severe impairment of func-
tioning of the clock gene machinery. Even though
this study did not allow to establish a direct associa-
tion between clock gene impairment and circadian
behavioral changes, our novel findings encourage
future studies testing the hypothesis that altered clock
gene expression may account for the disruption of
timely organization among brain areas, hampering
the coordination between basic cellular metabolic
and homeostatic processes, ultimately leading to
altered functionality and connectivity of brain struc-
tures, cognitive impairment and chrono-disruption
that characterize the early onset of AD in patients.
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